Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and ...
FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...
Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...
Clinical Trials Arena on MSN
Pharma positions itself for 2026 amid an evolving US landscape
From tariffs and onshoring to MFN, the US has seen significant policy developments - but how will these impact pharma in 2026 ...
Our data show that global pharma M&A is becoming more selective and strategically targeted. While North America remains the ...
As pharmaceutical markets become more specialized and competitive, commercial and medical affairs teams must use technology and collaboration to make faster, better-informed decisions, Lance Hill, ...
Halozyme Therapeutics has been busy. While fighting a patent dispute with Merck & Co. and navigating the impact of the Inflation Reduction Act (IRA), the company has penned an acquisition of fellow ...
India has become a leading pharma outsourcing hub, where top CDMOs stand out through compliance, capacity, technology, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback